NEW YORK (360Dx) – Laboratory Corporation of America, Sysmex, and Diazyme Laboratories were among the companies that received US Food and Drug Administration clearances in October for their in vitro diagnostic tests, according to the FDA website.

The FDA cleared LabCorp's Extended Lipid Panel Assay for quantitative determination in human serum and plasma of total cholesterol, high density lipoprotein cholesterol, and triglycerides in human serum and plasma, as well as of apolipoprotein B in human serum, running on the LipoScience Vantera Clinical Analyzer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.